ArticleBiomedical optics express2025
MulitDeepsurv: survival analysis of gastric cancer based on deep learning multimodal fusion models.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Artificial Intelligence in Gastric Cancer: Diagnostic, Prognostic, and Predictive Developments, Evidence Maturity, and Translational Challenges.Cancer reports (Hoboken, N.J.) · 2026Review
- Artificial intelligence for biomarker prediction in gastric cancer: from histopathology to multimodal integration.Frontiers in oncology · 2026Review
- Multitask learning for early treatment response and survival prediction in lung cancer radiotherapy using sequential CBCT imaging.Frontiers in oncology · 2026Article
- Advances in Technology and Applications of Optical Sensing and Imaging for Biomedicine: introduction to the feature issue.Biomedical optics express · 2025Article
- Interpretable deep learning for gastric cancer detection: a fusion of AI architectures and explainability analysis.Frontiers in immunology · 2025Article
- The Role of Neural Network Analysis in Identifying Predictors of Gastric Cancer.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer is a leading cause of cancer-related deaths globally. As mortality rates continue to rise, predicting cancer survival using multimodal data-including histopathological images, genomic data, and clinical information-has become increasingly crucial. However, extracting effective predictive features from this complex data has posed challenges for survival analysis due to the high dimensionality and heterogeneity of histopathology images and genomic data. Furthermore, existing methods often lack sufficient interaction between intra- and inter-modal features, significantly impacting model performance. To address these challenges, we developed a deep learning-based multimodal feature fusion model, MultiDeepsurv, designed to predict the survival of gastric cancer patients by integrating histopathological images, clinical data, and gene expression data. Our approach includes a two-branch hybrid network, GLFUnet, which leverages the attention mechanism for enhanced pathology image representation learning. Additionally, we employ a graph convolutional neural network (GCN) to extract features from gene expression data and clinical information. To capture the correlations between different modalities, we utilize the SFusion fusion strategy that employs a self-attention mechanism to learn potential correlations across modalities. Finally, these deeply processed features are fed into Cox regression models for an end-to-end survival analysis. Comprehensive experiments and analyses conducted on a gastric cancer cohort from The Cancer Genome Atlas (TCGA) demonstrate that our proposed MultiDeepsurv model outperforms other methods in terms of prognostic accuracy, with a C-index of 0.806 and an AUC of 0.842.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.